BAY 2666605 is a potent, orally bioavailable dual inhibitor of PDE3A (IC50=87 nM) and PDE3B (IC50=50 nM). This research compound exhibits anticancer activity and is utilized in preclinical studies to investigate PDE3 signaling in cellular proliferation and tumor models.
Molecular Weight:
352.28
Purity:
99.98% (May vary between batches)
CAS Number:
[2275774-60-0]
Formula:
C17H12F4N2O2
Target:
PDE
Application Notes:
Solubility: DMSO:245 mg/mL (695.47 mM)
* VAT and and shipping costs not included. Errors and price changes excepted